Chesapeake — Shareholder Meeting (April 2008)
19 slides from Chesapeake's shareholder meeting presentation, Apr 24, 2008
Slide 1: Chesapeake Annual Meeting April 23, 2008
Chesapeake Annual Meeting April 23, 2008
Slide 2: Leading Market Positions
Chesapeake Leading Market Positions • Pharmaceutical and healthcare packaging in Europe • Specialty chemicals packaging in Europe • Confectionery packaging in Germany and the U.K. • Alcoholic drinks packaging in Europe • Irish dairy packaging
Slide 3: Pharmaceuticals, Specialty Plastics, Branded Products
Pharmaceuticals Specialty Plastics Branded Products We Protect and Promote the World’s Great Brands
Slide 4: Financial Summary
$ in millions, except EPS ¹ Excludes special items Financial Summary 2006 2007 Sales $ 995.4 $1,059.6 Operating Income¹ 44.9 41.0 Income (loss) from continuing operations¹ 7.0 (1.9) EPS¹ $ 0.36 $ (0.10)
Slide 5: Three Focus Areas
Three Focus Areas • Operational • Strategic • Structural
Slide 6: Three Focus Areas: Operational Issues
Three Focus Areas 1 . Operational Issues – $25-million cost savings program launched in 2006 – Reached initial target in 2007 but cost reduction and rationalization efforts continue – Continued focus on fundamentals • Discovered practices to save $400K/year in Belfast
Slide 7: Three Focus Areas: Strategic Direction
Three Focus Areas 2. Strategic Direction – Pharmaceutical and Healthcare Packaging • Ethical and generic prescription medicines • Over-the-counter (OTC) medicines • Healthcare products • Medical devices • Toiletries – Branded Products Packaging • Alcoholic drinks and confectioneries – Plastic Packag
Slide 8: Global Reach with Local Touch
“Global Reach with Local Touch” Pharmaceutical and Healthcare Packaging • Ties to majority of Top 20 global pharmaceutical companies • Expect 5 percent annual growth in worldwide pharma packaging • Twenty-five dedicated sites in U.S., Europe and Asia
Slide 9: Pharmaceutical and Healthcare Packaging
Pharmaceutical and Healthcare Packaging • Intend to leverage position and expand geographically into S.E. Asia, Poland, India, Puerto Rico and South America • New five-year supply agreement with GSK or new weight-loss product • First and only pharma plant in China to earn S9000 certification
Slide 10: First Plant in China with PS9000 Certification
First Plant in China with PS9000 Certification
Slide 11: Looking Ahead
Looking Ahead • Targeting 8 percent earnings growth and EBITDA margins of 15 percent • Shifting our footprint eastward and increasing presence in emerging markets • Believe we can increase sales dramatically to pharmaceutical and healthcare customers
Slide 12: New Developments - Plastic Packaging Plant in Hungary
New Developments -- Plastic Packaging Plant in Hungary
Slide 13: New Developments - Consolidated Carton, Tubes and Labels in Scotland
New Developments - Consolidated Carton, Tubes and Labels for Alcoholic Drinks in Scotland
Slide 14: New Developments - Anti-Static Container
New Developments - Anti-Static Container
Slide 15: Three Focus Areas: Financial Structure
Three Focus Areas 3. Financial Structure – Debt level and refinancing uncertainty have hurt our stock and bond prices – Significant progress made on refinancing – Focus on pension obligations • Frozen or closed most defined benefit plans • U.K. pension plan is under-funded
Slide 16: We Protect and Promote the World's Great Brands
We Protect and Promote the World’s Great Brands
Slide 17: Disclaimer
Disclaimer This presentation contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The accuracy of such statements is subject to a number of risks, uncertainties and assumptions that may cause Chesapeake's ac
Slide 18: Reconciliation of Non-GAAP Financial Measures
Disclaimer Full Year 2007 2006 RECONCILIATION OF NON-GAAP FINANCIAL MEASURES ($ in millions) Operating (loss) income $ 26.7 $ 0.3 Add: goodwill impairment charge - -- 14.3 Add: restructuring expenses, asset impairments and other exit costs 15.8 33.4 Add: (gain) loss on divestitures (1.5) (3.1) Opera
Slide 19: Chesapeake Annual Meeting April 23, 2008
Chesapeake Annual Meeting April 23, 2008